| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 118.48B | 114.05B | 106.62B | 107.99B | 88.33B | 73.91B |
| Gross Profit | 30.69B | 30.31B | 28.76B | 27.43B | 23.13B | 21.30B |
| EBITDA | 9.65B | 9.54B | 8.88B | 8.79B | 4.97B | 5.51B |
| Net Income | 2.23B | 2.78B | 2.24B | 2.05B | -83.00M | 543.00M |
Balance Sheet | ||||||
| Total Assets | 118.13B | 124.35B | 114.84B | 111.79B | 104.06B | 91.06B |
| Cash, Cash Equivalents and Short-Term Investments | 17.24B | 20.30B | 17.48B | 14.44B | 13.71B | 17.60B |
| Total Debt | 33.19B | 33.95B | 33.90B | 35.31B | 31.18B | 22.52B |
| Total Liabilities | 56.98B | 60.31B | 57.04B | 58.86B | 53.83B | 42.92B |
| Stockholders Equity | 61.06B | 63.94B | 57.68B | 52.81B | 50.12B | 48.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.74B | 6.51B | -288.00M | -8.25B | 1.23B |
| Operating Cash Flow | 0.00 | 9.08B | 9.51B | 2.18B | -4.95B | 5.05B |
| Investing Cash Flow | 0.00 | -3.90B | -2.67B | -2.64B | -4.62B | -3.05B |
| Financing Cash Flow | 0.00 | -3.64B | -4.01B | 591.00M | 4.54B | -767.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥6.75T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
70 Outperform | ¥37.30B | 10.46 | ― | 4.53% | -2.57% | 3.43% | |
69 Neutral | ¥53.39B | 33.92 | 3.63% | 2.25% | 11.74% | -30.96% | |
67 Neutral | ¥3.97T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥33.14B | 2.72 | ― | 1.95% | 6.10% | ― | |
56 Neutral | ¥515.91B | 15.62 | ― | 2.57% | 4.81% | -49.43% |